Literature DB >> 23430947

Methionine Adenosyltransferase I/III Deficiency in Portugal: High Frequency of a Dominantly Inherited Form in a Small Area of Douro High Lands.

E Martins1, A Marcão, A Bandeira, H Fonseca, C Nogueira, L Vilarinho.   

Abstract

Methionine adenosyltransferase deficiency (MAT I/III deficiency) is an inborn error of metabolism resulting in isolated hypermethioninemia, and usually inherited as an autosomal recessive trait, although a dominant form has been reported in several families.During the last 6 years, approximately 520,000 newborns were screened in the Portuguese Newborn Screening Laboratory by MS/MS, and 21 cases of persistent hypermethioninemia were found. One case was confirmed to be a deficiency of cystathionine β-synthase and 20 cases were confirmed by MAT1A gene analysis to have an elevation of methionine due to MAT I/III deficiency, which indicates an incidence for this condition of 1/26,000. Twelve of the MAT I/III deficient newborns, belonging to 11 families, were identified in the northern region of Portugal and sent to the same treatment center, where they are under follow-up. Clinical, biochemical, and genetic characteristics of individuals from these 11 families are presented. Plasma methionine and homocysteine concentrations were found to be moderately increased in all newborns, and molecular analysis revealed that they all were heterozygous for R264H mutation. Normal growth, development, and neurological examination were observed in all cases, and cerebral MRI performed in six cases revealed myelination abnormalities in one case. Plasma methionine concentration for all 12 cases was always below 300 μM, and they are all on a normal diet for their age.

Entities:  

Year:  2012        PMID: 23430947      PMCID: PMC3565625          DOI: 10.1007/8904_2011_124

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  14 in total

1.  Biochemical basis for the dominant inheritance of hypermethioninemia associated with the R264H mutation of the MAT1A gene. A monomeric methionine adenosyltransferase with tripolyphosphatase activity.

Authors:  I Pérez Mato; M M Sanchez del Pino; M E Chamberlin; S H Mudd; J M Mato; F J Corrales
Journal:  J Biol Chem       Date:  2001-01-30       Impact factor: 5.157

2.  Four years of expanded newborn screening in Portugal with tandem mass spectrometry.

Authors:  Laura Vilarinho; Hugo Rocha; Carmen Sousa; Ana Marcão; Helena Fonseca; Mário Bogas; Rui Vaz Osório
Journal:  J Inherit Metab Dis       Date:  2010-02-23       Impact factor: 4.982

3.  Methionine adenosyltransferase (MAT) I/III deficiency with concurrent hyperhomocysteinaemia: two novel cases.

Authors:  M Linnebank; F Lagler; A C Muntau; W Röschinger; B Olgemöller; B Fowler; H G Koch
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

4.  Demyelination of the brain is associated with methionine adenosyltransferase I/III deficiency.

Authors:  M E Chamberlin; T Ubagai; S H Mudd; W G Wilson; J V Leonard; J Y Chou
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

5.  Dominant inheritance of isolated hypermethioninemia is associated with a mutation in the human methionine adenosyltransferase 1A gene.

Authors:  M E Chamberlin; T Ubagai; S H Mudd; H L Levy; J Y Chou
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

6.  Spectrum of hypermethioninemia in neonatal screening.

Authors:  Yin-Hsiu Chien; Shu-Chuan Chiang; Aichu Huang; Wuh-Liang Hwu
Journal:  Early Hum Dev       Date:  2004-12-19       Impact factor: 2.079

7.  Methionine adenosyltransferase I/III deficiency: novel mutations and clinical variations.

Authors:  M E Chamberlin; T Ubagai; S H Mudd; J Thomas; V Y Pao; T K Nguyen; H L Levy; C Greene; C Freehauf; J Y Chou
Journal:  Am J Hum Genet       Date:  2000-02       Impact factor: 11.025

Review 8.  Inherited disorders in the conversion of methionine to homocysteine.

Authors:  Ivo Barić
Journal:  J Inherit Metab Dis       Date:  2009-07-07       Impact factor: 4.982

9.  Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry.

Authors:  M S Rashed; P T Ozand; M P Bucknall; D Little
Journal:  Pediatr Res       Date:  1995-09       Impact factor: 3.756

Review 10.  The homocysteine controversy.

Authors:  Yvo M Smulders; Henk J Blom
Journal:  J Inherit Metab Dis       Date:  2010-06-22       Impact factor: 4.982

View more
  14 in total

1.  Newborn Screening for Homocystinuria Revealed a High Frequency of MAT I/III Deficiency in Iberian Peninsula.

Authors:  Ana Marcão; María L Couce; Célia Nogueira; Helena Fonseca; Filipa Ferreira; José M Fraga; M Dolores Bóveda; Laura Vilarinho
Journal:  JIMD Rep       Date:  2015-02-01

2.  Thirteen Patients with MAT1A Mutations Detected Through Newborn Screening: 13 Years' Experience.

Authors:  S Chadwick; K Fitzgerald; B Weiss; C Ficicioglu
Journal:  JIMD Rep       Date:  2014-01-21

3.  Methionine Exposure Alters Glutamate Uptake and Adenine Nucleotide Hydrolysis in the Zebrafish Brain.

Authors:  Fernanda Cenci Vuaden; Luiz Eduardo Baggio Savio; Eduardo Pacheco Rico; Ben Hur Marins Mussulini; Denis Broock Rosemberg; Diogo Losch de Oliveira; Maurício Reis Bogo; Carla Denise Bonan; Angela T S Wyse
Journal:  Mol Neurobiol       Date:  2014-11-25       Impact factor: 5.590

4.  MRI and (1)H-MRS in adenosine kinase deficiency.

Authors:  C Staufner; H J Blom; C Dionisi-Vici; P Freisinger; N Makhseed; D Ballhausen; S Kölker; G F Hoffmann; I Harting
Journal:  Neuroradiology       Date:  2016-03-18       Impact factor: 2.804

5.  Determination of Autosomal Dominant or Recessive Methionine Adenosyltransferase I/III Deficiencies Based on Clinical and Molecular Studies.

Authors:  Yoo-Mi Kim; Ja Hye Kim; Jin Choi; Kim Gu-Hwan; Jae-Min Kim; Minji Kang; In-Hee Choi; Chong Kun Cheon; Young Bae Sohn; Marco Maccarana; Han-Wook Yoo; Beom Hee Lee
Journal:  Mol Med       Date:  2016-02-18       Impact factor: 6.354

6.  Confirmation that MAT1A p.Ala259Val mutation causes autosomal dominant hypermethioninemia.

Authors:  Michael J Muriello; Sarah Viall; Teodoro Bottiglieri; Kristina Cusmano-Ozog; Carlos R Ferreira
Journal:  Mol Genet Metab Rep       Date:  2017-07-15

7.  Methionine adenosyltransferase I/III deficiency: beyond the central nervous system manifestations.

Authors:  Marwan Nashabat; Sultan Al-Khenaizan; Majid Alfadhel
Journal:  Ther Clin Risk Manag       Date:  2018-02-02       Impact factor: 2.423

Review 8.  Mudd's disease (MAT I/III deficiency): a survey of data for MAT1A homozygotes and compound heterozygotes.

Authors:  Yin-Hsiu Chien; Jose E Abdenur; Federico Baronio; Allison Anne Bannick; Fernando Corrales; Maria Couce; Markus G Donner; Can Ficicioglu; Cynthia Freehauf; Deborah Frithiof; Garrett Gotway; Koichi Hirabayashi; Floris Hofstede; George Hoganson; Wuh-Liang Hwu; Philip James; Sook Kim; Stanley H Korman; Robin Lachmann; Harvey Levy; Martin Lindner; Lilia Lykopoulou; Ertan Mayatepek; Ania Muntau; Yoshiyuki Okano; Kimiyo Raymond; Estela Rubio-Gozalbo; Sabine Scholl-Bürgi; Andreas Schulze; Rani Singh; Sally Stabler; Mary Stuy; Janet Thomas; Conrad Wagner; William G Wilson; Saskia Wortmann; Shigenori Yamamoto; Maryland Pao; Henk J Blom
Journal:  Orphanet J Rare Dis       Date:  2015-08-20       Impact factor: 4.123

Review 9.  Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines.

Authors:  Martina Huemer; Viktor Kožich; Piero Rinaldo; Matthias R Baumgartner; Begoña Merinero; Elisabetta Pasquini; Antonia Ribes; Henk J Blom
Journal:  J Inherit Metab Dis       Date:  2015-03-12       Impact factor: 4.982

Review 10.  Consensus recommendations for the diagnosis, treatment and follow-up of inherited methylation disorders.

Authors:  Ivo Barić; Christian Staufner; Persephone Augoustides-Savvopoulou; Yin-Hsiu Chien; Dries Dobbelaere; Sarah C Grünert; Thomas Opladen; Danijela Petković Ramadža; Bojana Rakić; Anna Wedell; Henk J Blom
Journal:  J Inherit Metab Dis       Date:  2016-09-26       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.